(S)-[6]-gingerol enhances glucose uptake in L6 myotubes by activation of AMPK in response to [ca2+]i

Journal of Pharmacy and Pharmaceutical Sciences

Volumn 16, Issue 2, 2013, Pages 304-312

  Li, Yiming ^a   Tran, Van H ^a   Koolaji, Nooshin ^a   Duke, Colin C ^a   Roufogalis, Basil D ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

(6) GINGEROL; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE; CALCIUM ION; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE;

ANIMAL CELL; ANTIDIABETIC ACTIVITY; ARTICLE; CELL JUNCTION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INDUCTION; ENZYME PHOSPHORYLATION; GINGER; GLUCOSE TRANSPORT; MYOTUBE; NONHUMAN; RAT; TIMED DRUG RELEASE;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; CALCIUM; CATECHOLS; CELL LINE; FATTY ALCOHOLS; GLUCOSE; HYPOGLYCEMIC AGENTS; MUSCLE FIBERS, SKELETAL; RATS; RNA, SMALL INTERFERING;

EID: 84890134026     PISSN: None     EISSN: 14821826     Source Type: Journal    
DOI: 10.18433/j34g7p     Document Type: Article

References (41)

1. Lage R, Dieguez C, Vidal-Puig A, Lopez M. AMPK: a metabolic gauge regulating whole-body energy homeostasis. Trends in Molecular Medicine. 2008; 12: 539-549.
2. Witczak CA, Sharoff CG, Goodyear LJ. AMPactivated protein kinase in skeletal muscle: From structure and localization to its role as a master regulator of cellular metabolism. Cellular and Molecular Life Sciences. 2008; 23: 3737-3755.
3. Hawley SA, Davison M, Woods A, Davies SP, Beri RK, Carling D, Hardie DG. Characterization of the AMP-activated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase. The Journal of biological chemistry. 1996; 44: 27879-27887.
4. Stein SC, Woods A, Jones NA, Davison MD, Carling D. The regulation of AMP-activated protein kinase by phosphorylation. Biochem J. 2000; 437-443.
5. Hawley SA, Selbert MA, Goldstein EG, Edelman AM, Carling D, Hardie DG. 5'-AMP activates the AMP-activated protein kinase cascade, and Ca2+/calmodulin activates the calmodulindependent protein kinase I cascade, via three independent mechanisms. J Biol Chem. 1995; 45: 27186-27191.
6. Woods A, Johnstone SR, Dickerson K, Leiper FC, Fryer LG, Neumann D, Schlattner U, Wallimann T, Carlson M, Carling D. LKB1 is the upstream kinase in the AMP-activated protein kinase cascade. Curr Biol. 2003; 22: 2004-2008.
7. Momcilovic M, Hong SP, Carlson M. Mammalian TAK1 activates Snf1 protein kinase in yeast and phosphorylates AMP-activated protein kinase in vitro. J Biol Chem. 2006; 35: 25336-25343.
8. Merrill GF, Kurth EJ, Rasmussen BB, Winder WW. Influence of malonyl-CoA and palmitate concentration on rate of palmitate oxidation in rat muscle. J Appl Physiol. 1998; 5: 1909-1914.
9. Merrill GF, Kurth EJ, Hardie DG, Winder WW. AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle. Am J Physiol. 1997; 6 Pt 1: E1107-1112.
10. Kurth-Kraczek EJ, Hirshman MF, Goodyear LJ, Winder WW. 5' AMP-activated protein kinase activation causes GLUT4 translocation in skeletal muscle. Diabetes. 1999; 8: 1667-1671.
11. Nammi S, Sreemantula S, Roufogalis BD. Protective effects of ethanolic extract of Zingiber officinale rhizome on the development of metabolic syndrome in high-fat diet-fed rats. Basic & clinical pharmacology & toxicology. 2009; 5: 366-373.
12. Sekiya K, Ohtani A, Kusano S. Enhancement of insulin sensitivity in adipocytes by ginger. Biofactors. 2004; 1-4: 153-156.
13. Noipha K, Ratanachaiyavong S, Ninla-Aesong P. Enhancement of glucose transport by selected plant foods in muscle cell line L6. Diabetes Res Clin Pract. 2010; 2: e22-26.
14. Li Y, Tran VH, Duke CC, Roufogalis BD. Gingerols of Zingiber officinale enhance glucose uptake by increasing cell surface GLUT4 in cultured L6 myotubes. Planta Med. 2012; 14: 1549-1555.
15. Hutchinson DC, Bentgsson T. AMP-activated protein kinase activation by adrenoceptors in L6 skeletal muscle cells: mediation by alpha1- adrenoceptors causing glucose uptake. Diabetes. 2006; 55: 682-690.
16. Tokumitsu H, Inuzuka H, Ishikawa Y, Ikeda M, Saji I, Kobayashi R. STO-609, a specific inhibitor of the Ca(2+)/calmodulin-dependent protein kinase kinase. J Biol Chem. 2002; 18: 15813-15818
17. Pehmoller C, Treebak JT, Birk JB, Chen S, Mackintosh C, Hardie DG, Richter EA, Wojtaszewski JF. Genetic disruption of AMPK signaling abolishes both contraction- and insulinstimulated TBC1D1 phosphorylation and 14-3-3 binding in mouse skeletal muscle. Am J Physiol Endocrinol Metab. 2009; 3: E665-675.
18. Chen S, Murphy J, Toth R, Campbell DG, Morrice NA, Mackintosh C. Complementary regulation of TBC1D1 and AS160 by growth factors, insulin and AMPK activators. Biochem J. 2008; 2: 449-459.
19. Kahn BB, Alquier T, Carling D, Hardie DG. AMPactivated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell metabolism. 2005; 1: 15-25.
20. Liang H, Ward WF. PGC-1alpha: a key regulator of energy metabolism. Adv Physiol Educ. 2006; 4: 145-151.
21. Hardie DG. AMP-activated protein kinase: a cellular energy sensor with a key role in metabolic disorders and in cancer. Biochem Soc Trans. 2011; 1: 1-13.
22. Wu Z, Puigserver P, Andersson U, Zhang C, Adelmant G, Mootha V, Troy A, Cinti S, Lowell B, Scarpulla RC, Spiegelman BM. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell. 1999; 1: 115-124.
23. Gruzman A, Babai G, Sasson S. Adenosine Monophosphate-Activated Protein Kinase (AMPK) as a New Target for Antidiabetic Drugs: A Review on Metabolic, Pharmacological and Chemical Considerations. Rev Diabet Stud. 2009; 1: 13-36.
24. Ruderman N, Prentki M. AMP kinase and malonyl- CoA: targets for therapy of the metabolic syndrome. Nat Rev Drug Discov. 2004; 4: 340-351.
25. An J, Muoio DM, Shiota M, Fujimoto Y, Cline GW, Shulman GI, Koves TR, Stevens R, Millington D, Newgard CB. Hepatic expression of malonyl-CoA decarboxylase reverses muscle, liver and wholeanimal insulin resistance. Nat Med. 2004; 3: 268-274.
26. Clapham DE. Calcium signaling. Cell. 2007; 6: 1047-1058.
27. Berridge MJ, Bootman MD, Roderick HL. Calcium signalling: dynamics, homeostasis and remodelling. Nat Rev Mol Cell Biol. 2003; 7: 517-529.
28. Dedov VN, Tran VH, Duke CC, Connor M, Christie MJ, Mandadi S, Roufogalis BD. Gingerols: a novel class of vanilloid receptor (VR1) agonists. Br J Pharmacol. 2002; 6: 793-798.
29. Chen CY, Chen CH, Kung CH, Kuo SH, Kuo SY. [6]-gingerol induces Ca2+ mobilization in Madin- Darby canine kidney cells. J Nat Prod. 2008; 1: 137-140.
30. Foley K, Boguslavsky S, Klip A. Endocytosis, recycling, and regulated exocytosis of glucose transporter 4. Biochemistry. 2011; 15: 3048-3061.
31. Lopez JA, Burchfield JG, Blair DH, Mele K, Ng Y, Vallotton P, James DE, Hughes WE. Identification of a distal GLUT4 trafficking event controlled by actin polymerization. Mol Biol Cell. 2009; 17: 3918-3929.
32. Furuta A, Tanaka M, Omata W, Nagasawa M, Kojima I, Shibata H. Microtubule disruption with BAPTA and dimethyl BAPTA by a calcium chelation-independent mechanism in 3T3-L1 adipocytes. Endocr J. 2009; 2: 235-243.
33. Worrall DS, Olefsky JM. The effects of intracellular calcium depletion on insulin signaling in 3T3-L1 adipocytes. Mol Endocrinol. 2002; 2: 378-389.
34. Whitehead JP, Molero JC, Clark S, Martin S, Meneilly G, James DE. The role of Ca2+ in insulinstimulated glucose transport in 3T3-L1 cells. J Biol Chem. 2001; 30: 27816-27824.
35. Verhoeven AJ, Woods A, Brennan CH, Hawley SA, Hardie DG, Scott J, Beri RK, Carling D. The AMPactivated protein kinase gene is highly expressed in rat skeletal muscle. Alternative splicing and tissue distribution of the mRNA. Eur J Biochem. 1995; 2: 236-243.
36. Woods A, Salt I, Scott J, Hardie DG, Carling D. The alpha1 and alpha2 isoforms of the AMPactivated protein kinase have similar activities in rat liver but exhibit differences in substrate specificity in vitro. FEBS Lett. 1996;: 347-351.
37. Salt I, Celler JW, Hawley SA, Prescott A, Woods A, Carling D, Hardie DG. AMP-activated protein kinase: greater AMP dependence, and preferential nuclear localization, of complexes containing the alpha2 isoform. Biochem J. 1998; 177-187.
38. Viollet B, Andreelli F, Jorgensen SB, Perrin C, Geloen A, Flamez D, Mu J, Lenzner C, Baud O, Bennoun M, Gomas E, Nicolas G, Wojtaszewski JF, Kahn A, Carling D, Schuit FC, Birnbaum MJ, Richter EA, Burcelin R, Vaulont S. The AMPactivated protein kinase alpha2 catalytic subunit controls whole-body insulin sensitivity. J Clin Invest. 2003; 1: 91-98.
39. Jorgensen SB, Viollet B, Andreelli F, Frosig C, Birk JB, Schjerling P, Vaulont S, Richter EA, Wojtaszewski JF. Knockout of the alpha2 but not alpha1 5'-AMP-activated protein kinase isoform abolishes 5-aminoimidazole-4-carboxamide-1- beta-4-ribofuranosidebut not contraction-induced glucose uptake in skeletal muscle. J Biol Chem. 2004; 2: 1070-1079.
40. Bruce CR, Mertz VA, Heigenhauser GJ, Dyck DJ. The stimulatory effect of globular adiponectin on insulin-stimulated glucose uptake and fatty acid oxidation is impaired in skeletal muscle from obese subjects. Diabetes. 2005; 11: 3154-3160.
41. Egawa T, Hamada T, Ma X, Karaike K, Kameda N, Masuda S, Iwanaka N, Hayashi T. Caffeine activates preferentially alpha1-isoform of 5'AMPactivated protein kinase in rat skeletal muscle. Acta Physiol (Oxf). 2011; 2: 227-238.